Asset | Indication | Pre-Clinical | IND-Enabling Studies | Phase 1 | Phase 2 | Phase 3 |
---|---|---|---|---|---|---|
OK-101 |
Dry Eye | started phase 2 in Q2/2023 | ||||
Uveitis | ||||||
Allergic Conjunctivitis | ||||||
Ocular Pain | OK-201 |
Discovery Program |
Drug | Indication | Stage |
---|---|---|
OK-101 |
Dry Eye | Phase 1* |
Uveitis | Pre-Clinical | |
Allergic Conjunctivitis | Pre-Clinical | |
Ocular Pain | Pre-Clinical | OK-201 |
Discovery Program |
*started phase 2 in Q2/2023